Fig. 1From: Emerging therapeutic agents for advanced non-small cell lung cancerMutation frequency of lung adenocarcinoma and emerging drugs targeted these mutations. Frequency data is a combination from the AACR GENIE data and Lung Cancer Mutation Consortium [73, 74]Back to article page